ALB
ALBEMARLE CORPEvidence as of 2026-09-02Overview · ALBEMARLE CORP
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electroni…
Management team
- Mr. Mark R. Mummert · Senior VP, Chief Capital, Resources & Integrated Supply Chain OfficerFind on LinkedIn
- Ms. Cynthia Renee Lima · Senior VP and Chief External Affairs & Communications OfficerFind on LinkedIn
- Mr. Eric W. Norris · Executive VP & Chief Commercial OfficerFind on LinkedIn
- Ms. Melissa H. Anderson · Executive VP and Chief People & Transformation OfficerFind on LinkedIn
Start your 7-day free trial to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
Moneyta sentiment
Where the published evidence leans after the desk debated it — not a rating or a recommendation.
+0.3 on a −2 to +2 scale.
What builds the score
Solid bars are analyst rubric scores; faded bars are computed directly from data. Claims dropped in debate count for nothing; weakened claims count at half weight.
Editor's note
Written after the debate settled — the rest of the page is the evidence behind it.
The evidence balance is Mixed (+0.3 of a possible +2; was +0.3 before the debate) with confidence high. Revenues rose from $ 1,428,731,000 in Q1 2026 (fiscal quarter ended 2026-04-29) to $ 1,743,313,000 in Q2 2026 (fiscal quarter ended 2026-07-29), an increase of $ 314,582,000 (about 22.0%). Operating income increased from $ 233,506,000 to $ 452,944,000 across those quarters and operating margin improved from roughly 16.3% to roughly 26.0%, while gross profit moved from $ 500,966,000 to $ 590,301,000 and gross margin compressed slightly from ~35.1% to ~33.9%.
Net income rose from $ 319,091,000 to $ 479,959,000 and diluted EPS from $ 2.34 to $ 3.52. Point-in-time long-term debt fell from $ 3,193,541,000 as of 2025-12-31 to $ 1,881,831,000 as of 2026-03-31 and $ 1,876,787,000 as of 2026-06-30. Market and ownership signals are mixed: three‑month momentum was -20.9% as of 2026-09-01 while a 12‑month minus 1‑month momentum measure was +77.3% (90th percentile); 90‑day annualized volatility was 47.4% and maximum drawdown over three years was -74.1%. Institutional 13F‑reported holdings were $ 586,857 as of 2026-03-31, a quarter‑over‑quarter reported value change of -49.8% with three reported institutional holders. The filings record an 8‑K dated 2026-08-21 naming Max W. Hood as Chief Accounting Officer and summarizing his compensation and grant terms. Valuation signals in the packet show an implied FCF growth requirement of 28.61% per year, P/FCF (TTM) 42.74, EV/EBITDA (TTM) 13.95, P/E (TTM) 34.06, FCF TTM $ 431,966,000 and operating cash flow TTM $ 1,711,916,000.
How this note was made
every stage ran before the note was writtenAnalyst desk
Mercer, Oakes, Nash, Ellis, Yates, Talbot and Archer. The desk: named AI agents, not people. Each reads one slice of the evidence and nothing else — no outside knowledge, no browsing — so every finding traces to a source you can open.
Reads the XBRL figures companies file with the SEC — revenue, margins, income, debt and share count, quarter by quarter — and reports which way the trend is running.
Revenues rose from $1,428,731,000 in fiscal Q1 2026 (2026-01-01 to 2026-03-31) to $1,743,313,000 in fiscal Q2 2026 (2026-04-01 to 2026-06-30), an increase of $314,582,000 (about 22.0%).
XBRL companyfacts · 0000915913-26-000072Operating income increased from $233,506,000 in fiscal Q1 2026 (2026-01-01 to 2026-03-31) to $452,944,000 in fiscal Q2 2026 (2026-04-01 to 2026-06-30), an increase of $219,438,000, and operating margin improved from ~16.3% to ~26.0% using those quarters' revenues.
XBRL companyfacts · 0000915913-26-000072Reads the filings themselves, above all the year-over-year diff of Item 1A risk factors: which risks a company added, dropped or quietly reworded since its last annual report.
Which filings the desk reads
The desk reads the annual 10-K in full — its risk factors, and how they changed since last year. Quarterly 10-Qs and event filings (8-Ks, insider Form 4s) are listed for context but not read line by line: the 10-K is where the material risk disclosures live. A brand-new company, or one we have only just begun tracking, may have no annual report on file yet — its risk analysis fills in once that lands.
On August 21, 2026 (8-K filed that date), Albemarle's Board appointed Max W. Hood as Chief Accounting Officer, effective August 24, 2026, and he will assume the role of the Company's principal accounting officer.
8-K filed 2026-08-21The 8-K filed August 21, 2026 states Mr. Hood most recently served as co-Chief Financial Officer of The ODP Corporation and previously held finance and accounting leadership roles at General Electric Company and Deloitte.
8-K filed 2026-08-21Reads the signal panel above — momentum, volatility, drawdown, relative strength and beta — and ranks each against the whole research universe rather than judging it in isolation.
ALB's momentum over the past 3 months was -20.9% as of 2026-09-01.
Moneyta signal set · 2026-09-01weakened in debateALB's momentum_12_1 (a 12-month minus 1-month momentum measure) was +77.3% and ranks in the 90th percentile of the 547-stock research universe as of 2026-09-01.
Moneyta signal set · 2026-09-01weakened in debateReads which funds hold the name and at what weight, plus insider Form 4 filings, to show the exposure you may already carry through index funds.
Institutional 13F-reported holdings in ALB total "$586,857" as of 2026-03-31.
13F holdings · 3 filers · as of 2026-03-31The 13F reporting shows a quarter-over-quarter reported value change of -49.8% for the period ended 2026-03-31.
13F holdings · 3 filers · as of 2026-03-31Reads recent headlines that are genuinely about this company, ignoring rating chatter and market-wide stories. Findings argue in the debate but never move the sentiment score.
Multiple filings-based reports from thelincolnianonline on 2026-08-29 through 2026-08-31 report several new institutional stakes in Albemarle (Rakuten Investment Management, The Manufacturers Life Insurance Company, Caisse de depot et placement du Quebec, and Legal & General Group Plc).
News · thelincolnianonline.com · 2026-08-31Thelincolnianonline published separate articles on 2026-08-30 and 2026-08-31 highlighting additional 13F-reported purchases in Albemarle by The Manufacturers Life Insurance Company and Caisse de depot et placement du Quebec.
News · thelincolnianonline.com · 2026-08-30Reads parsed Forms 3/4/5 — who bought or sold, at what size, and whether a 10b5-1 plan was involved. Flags clustered open-market officer buying; treats plan sales as routine and never counts a fund or 10%-holder as an officer.
No insider transactions on file in the trailing 180 days.
Reads the implied-expectations math built from the company's own filings (the growth rate today's price would justify, and the multiples beside it) and argues whether the market's bar looks high or low for this business. Never turns the math into a target.
The model-derived implied free cash flow (FCF) growth rate that today's price would justify, under the stated discount and terminal assumptions, is 28.61% per year.
Valuation inputs · SEC XBRL + stored EOD closePrice-to-free-cash-flow (P/FCF, trailing twelve months) is 42.74.
Valuation inputs · SEC XBRL + stored EOD closeDebate and risk review
A bull and a bear contest the claims and the chair rules on each; the risk review stress-tests what survived.
A bull and a bear argue the analysts' claims across two rounds, then a chair rules on each one. Only what survives feeds the score — the argument is shown, not hidden, so you can judge the reasoning yourself.
Several contemporaneous fundamentals point to an improving operating and profitability profile: sequential revenue growth of ~22%, operating income roughly doubling with a material expansion in operating margin, and net income and diluted EPS rising notably quarter-over-quarter. The company shows a meaningful reduction in reported long-term debt while trailing twelve-month free cash flow and operating cash flow remain positive, and 12-month momentum ranks in the 90th percentile of the research universe — institutional interest and recent 13F-reported purchases in late August add corroborating signals. Short-term price weakness, elevated short-horizon volatility, and a large recent drawdown are observable market responses, but historically, market-driven volatility can diverge from quarter-to-quarter fundamental improvements. Although model-derived implied FCF growth and valuation multiples read as rich, the trailing cash flow levels and improving margins provide substantive support for a favorable fundamental reading when weighing operational improvements against market pricing.
Chair's verdict, claim by claim
Fragility · computed, not argued
balanced0.35
33 surviving claims rest on 14 distinct sources; the heaviest analyst carries 18% of them, and 97% of what the desk raised survived the debate.
The read rests on a moderate spread of documentary sources but only 14 distinct items for 33 surviving claims, so individual sources can still move several claims together; the largest analyst contribution is below a fifth, which reduces single-analyst dependence. The very high survival rate from the desk debate suggests the claims were rarely challenged internally, which strengthens internal consistency but also implies limited falsification occurred during review — treat the bundle as informational but sensitive to a small set of documents/filings changing.
Peer context · computed, not argued
12-1 momentum ranks 1st of 2 in Specialty Chemicals (as of 2026-09-01).
6-month relative strength ranks 2nd of 2 in Specialty Chemicals (as of 2026-09-01).
90-day volatility ranks 1st of 2 in Specialty Chemicals (as of 2026-09-01).
Disconfirming evidence · base rates · falsifiers
Context
Outside consensus, and where this name already sits in your own portfolio.
Third-party consensus shown for context. It never enters Moneyta sentiment — when the two diverge, the debate above is where the why lives.
What this was built from
Every figure on this page traces to one of these. The desk reads only what is listed here — no outside knowledge, no browsing — and each card shows who read it and what it contributed to the score.
16 filings· 1 cited
SEC XBRL filings
Quarterly figures as filed with the SEC, read straight from EDGAR's structured data — not retyped or estimated.
Read by Mercer+0.7 to the score
3 documents· 2 cited
SEC filing documents
The filings themselves, including the year-over-year comparison of Item 1A risk factors.
Read by Oakes+1.0 to the score
1 signal set
Moneyta signal set
Computed from our own end-of-day price history and ranked against the whole research universe. No AI involved.
Read by Nash−0.5 to the score
2 holdings records· 1 cited
Fund holdings
Which funds hold this name and at what weight, plus insider Form 4 filings.
Read by Ellis+0.0 to the score
8 headlines· 2 cited
News coverage
Recent headlines about this company, rating chatter excluded and nothing published after the report date.
Read by Yatesnothing survived
1 computation
Valuation inputs
TTM cash-flow figures from the company's own XBRL filings, priced with the stored closing price. Implied growth and multiples only; no fair-value dollar figure reaches the desk, by design.
Read by Archercontext only
1 record· 0 cited
Company profile
Sector, industry and company details.
1 record· 0 cited
Analyst consensus
Third-party consensus, shown for context only — it never enters Moneyta sentiment.
Read means we pulled and handed it to an analyst; cited means a claim on this page points at it. Reading twelve quarters to state one trend is normal — the gap is shown rather than hidden.
Written by AI, checked against sources
The analysts, the bull–bear debate and the editor's note are AI agents reading only the evidence listed on this page. They can misread a filing or a headline, which is why every claim cites a source you can open and check yourself. The sentiment score is arithmetic over the claims that survived the debate, not a language model's opinion.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations. Past patterns do not indicate future results.
Get this for the tickers you actually hold
Plus the one thing no sample can show: how each name correlates with your portfolio, and what hides inside your funds.
The full terminal on ALB Gold
Who holds it, who's buying, what the Street thinks: live behind the lock, updated as filings land.
Institutional holders
Net institutional flow, Q/Q
Largest holder position
Insider buys, 90 days
Clustered insider value
Street target range
The real figures are for members. Educational analysis, not advice.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations.